Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CollPlant Biotechnologies (CLGN) Depreciation & Amortization (CF) (2019 - 2021)

Historic Depreciation & Amortization (CF) for CollPlant Biotechnologies (CLGN) over the last 3 years, with Q4 2021 value amounting to $224000.0.

  • CollPlant Biotechnologies' Depreciation & Amortization (CF) rose 3493.98% to $224000.0 in Q4 2021 from the same period last year, while for Sep 2022 it was $224000.0, marking a year-over-year decrease of 3829.2%. This contributed to the annual value of $1.0 million for FY2024, which is 580.76% down from last year.
  • CollPlant Biotechnologies' Depreciation & Amortization (CF) amounted to $224000.0 in Q4 2021, which was up 3493.98% from $197000.0 recorded in Q3 2021.
  • CollPlant Biotechnologies' Depreciation & Amortization (CF)'s 5-year high stood at $224000.0 during Q4 2021, with a 5-year trough of $97000.0 in Q1 2019.
  • For the 3-year period, CollPlant Biotechnologies' Depreciation & Amortization (CF) averaged around $162000.0, with its median value being $165000.0 (2020).
  • The largest annual percentage gain for CollPlant Biotechnologies' Depreciation & Amortization (CF) in the last 5 years was 6907.22% (2020), contrasted with its biggest fall of 177.51% (2020).
  • CollPlant Biotechnologies' Depreciation & Amortization (CF) (Quarter) stood at $169000.0 in 2019, then fell by 1.78% to $166000.0 in 2020, then surged by 34.94% to $224000.0 in 2021.
  • Its last three reported values are $224000.0 in Q4 2021, $197000.0 for Q3 2021, and $166000.0 during Q4 2020.